BioVaxys Partners with Enclave Capital for Private Placement Initiative BioVaxys Technology Corp. announces collaboration with Enclave Capital LLC for a brokered private placement offering aimed at financing its innovative immunotherapy projects.

BioVaxys Partners with Enclave Capital for Private Placement Initiative #Canada #Vancouver #Investment #BioVaxys #Enclave_Capital